Long, Smith, Quinn named to new positions at Roswell Park

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Mary Ann Long
Laurie J. Smith
Timothy Quinn

Three leaders were appointed to Roswell Park Comprehensive Cancer Center:

  • Mary Ann Long was named senior vice president of nursing. Long will focus on evaluating service in inpatient, outpatient and community practices, and will provide leadership to all nursing teams across the center.
    Long was previously director of Magnet at Roswell Park until her retirement in 2012, and also served as assistant director of nursing and director of patient care services, in addition to more than 30 years of service as an intensive care unit nurse.

  • Laurie J. Smith was named vice president of clinical research services. As vice president, Smith will support more than 400 active clinical trials a year and supervise staff engaged in study submission, study implementation, data collection and management.
    Smith previously served as an independent consultant and, prior to that, as vice president of clinical research for AMITA Health in Chicago.
  • Timothy Quinn was named chief of critical care. Quinn, previously co-director of the Intensive Care Unit, has been named to the newly created role of chief of critical care. He will work with members of Roswell Park’s Intensive Care Unit and Intermediate Care Unit to provide cutting-edge and evidence-based oncologic care to patients. A critical care anesthesiologist at the Center, Quinn’s research interests include preoperative evaluation of high-risk patients, intraoperative care and postoperative quality-improvement initiatives.
Table of Contents

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login